The information contained within this
announcement is deemed by the Company to constitute inside
information as stipulated under the UK version of the EU Market
Abuse Regulation (2014/596) which is part of UK law by virtue of
the European Union (Withdrawal) Act 2018, as amended and
supplemented from time to time.
22 April 2024
HeiQ
Plc
("HeiQ"
or "the Company")
HeiQ Synbio Secures Ecolab
Contract Win
HeiQ Plc (LSE: HEIQ), a leading
company in materials innovation and hygiene technologies, is
pleased to announce that its Life Sciences
Business Unit has signed a significant distributor
agreement with Ecolab Inc. (NYSE: ECL) to supply HeiQ Synbio
Cleaners, a product from the Company's industrial biotechnology
platform that uses natural synbiotic ingredients to achieve high
efficacy cleaning.
This five-year supply agreement with Ecolab, a world leader
in water, hygiene, and infection prevention solutions and services,
will see Ecolab offer its customers a range of cleaning products
developed using the HeiQ Synbio technology platform. HeiQ will
receive an initial upfront payment of €1.8 million to support the
investment needed for the first two years of market introduction,
and if successful, additional minimum contractual orders for the
following three years, generating minimum revenues of €11 million
in aggregate. Ecolab will have exclusive distribution rights
in the field of B2B cleaning for the European Union, EFTA countries
and the U.K.
The HeiQ Synbio technology platform
was developed by HeiQ Chrisal N.V., which became part of the HeiQ Group in Q2 2021 as one
of HeiQ's three capability building
acquisitions. This distributor agreement with Ecolab as a leading
hygiene channel partner follows HeiQ's significant investment into the HeiQ Synbio technology
platform during the last two years. The compounds have been awarded
the first EU Ecolabel for probiotic cleaning and are developed in
accordance with the new draft EU Detergent
Regulation.
Carlo Centonze, co-founder and CEO, HeiQ plc,
said: "We are thrilled to be
partnering with Ecolab, a global leader in the development and
distribution of hygiene and infection prevention solutions. This
agreement validates the disruptive qualities of our HeiQ Synbio
industrial biotech platform and its innovative first mover position
in the market.
"Our partnership will see us work
closely alongside Ecolab to co-develop further exciting and
innovative uses for our HeiQ Synbio technology platform, creating
the potential to open up additional new markets and application
fields. We are proud that with our HeiQ Synbio biotechnology we
contribute to improve people´s lives by adding hygiene, protection
and sustainability to products we use every day."
Adrian Studer, EVP & Market Head, Ecolab Europe said:
"Our customers in Europe are highly
focused on sustainable cleaning solutions and in an environment
where regulations are rapidly changing, this agreement is one
example of the steps we are taking to meet our customers´ evolving
goals and our own purpose to drive positive impact on the
planet.
"Working with HeiQ creates a
complementary product offering with interesting longer-lasting
environmental control in specific cleaning environments that works
together with our existing best-in-class cleaning solutions. We
look forward to leveraging the power of Ecolab´s deep market
expertise and our salesforce breadth to drive implementation across
Europe."
For
further information, please contact:
HeiQ Plc
Carlo Centonze (CEO)
|
+41 56 250 68 50
|
Cavendish Capital Markets Limited (Broker)
Stephen Keys / Callum
Davidson
|
+44 (0) 207 397 8900
|
SEC
Newgate (Media Enquiries)
Elisabeth Cowell / Molly Gretton /
Tom Carnegie
|
+44 (0) 20 3757 6882
HeiQ@secnewgate.co.uk
|
About HeiQ
Founded in 2005, HeiQ is a
Swiss-based international company that is a global leader in
biotech ingredients and specialty chemicals for diverse
applications such as textiles, flooring, building materials, glass,
plastics, probiotic cleaning, cosmetics, and more. Working with
more than 1000 partners in over 60 countries, our goal is to infuse
ordinary products with extraordinary qualities, offering our
co-creation partners sustainable and disruptive solutions across
industries. Our business model focuses on the commercialization of
existing and as well as the incubation of new technologies, driving
shareholder value through sales growth, entry into lucrative
markets, and disruptive innovation. Our business model consists of
three distinct platform technology ventures, being HeiQ AeoniQ,
HeiQ ECOS, and HeiQ GrapheneX, and three growth-orientated
commercialized business units financing our ventures, being HeiQ
Textiles & Flooring, HeiQ Life Sciences (probiotic industrial
biotech), and HeiQ Antimicrobials.
We have a robust track record of
innovation, with over 200 technologies developed in partnership
with 300 major brands, including Hanes, Burberry, HUGO BOSS, Lycra,
Zara, Itochu, Bosch Siemens, Ecolab,
Woellner, Americhem, Lixil, and many more.
Our global team comprises 230 professionals from 30 nationalities
across five continents. We're committed to shaping a future where
everyday products drive positive change, one innovation at a
time.
To learn more about HeiQ and our
innovative solutions, visit www.heiq.com.
About Ecolab
A trusted partner for millions of
customers, Ecolab (NYSE:ECL) is a global sustainability leader
offering water, hygiene and infection prevention solutions and
services that protect people and the resources vital to life.
Building on a century of innovation, Ecolab has annual sales of $15
billion, employs more than 48,000 associates and operates in more
than 170 countries around the world. The company delivers
comprehensive science-based solutions, data-driven insights and
world-class service to advance food safety, maintain clean and safe
environments, and optimize water and energy use. Ecolab's
innovative solutions improve operational efficiencies and
sustainability for customers in the food, healthcare, life
sciences, hospitality and industrial markets.